Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Directors Dealing error

28 Dec 2007 16:51

BrainJuicer Group PLC28 December 2007 BrainJuicer Group PLC ("BrainJuicer" or "the Company") "The following announcement released today at 11:38 RNS number 7471K was anerror and no transaction took place. The Following was the text of the announcement released earlier today: Directors Dealings BrainJuicer Group PLC, (AIM: BJU), a leading international online marketresearch agency, was today informed that John Kearon, Chief Executive Officer,has today purchased 4,000 Ordinary Shares of 1p each in the Company ("OrdinaryShares") at a price of 149.5p per Ordinary Share. Following this transaction,Mr. Kearon is interested in 5,664,187 Ordinary Shares, representing 45.03% ofthe total issued share capital of the Company." For further information, please contact:BrainJuicer plcJohn Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000 www.brainjuicer.comLandsbanki Securities (UK) LimitedFred Walsh / Simon Brown Tel: +44 (0)20 7426 9000 www.landsbanki.co.ukMedia enquiries:Abchurch CommunicationsHeather Salmond / Joanne Shears Tel: +44 (0) 20 7398 7700joanne.shears@abchurch-group.com www.abchurch-group.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Aug 202211:00 amRNSNotice of AGM
31st Aug 20227:00 amRNSDirectorate Change
31st Aug 20227:00 amRNSReview of strategic options
30th Aug 20226:00 pmRNSTransaction in Own Shares
19th Aug 20228:55 amRNSTransaction in Own Shares
3rd Aug 20225:45 pmRNSTransaction in Own Shares
2nd Aug 20223:45 pmRNSTransaction in Own Shares
29th Jul 20229:30 amRNSTransaction in Own Shares
26th Jul 20226:24 pmRNSTransaction in Own Shares
19th Jul 20224:00 pmRNSHolding(s) in Company
19th Jul 20223:00 pmRNSTransaction in Own Shares
18th Jul 20224:30 pmRNSTransaction in Own Shares
15th Jul 20225:15 pmRNSTransaction in Own Shares
12th Jul 20227:00 amRNSShare Buyback Programme
12th Jul 20227:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2022
12th Jul 20227:00 amRNSQuarterly Trading Update
30th Jun 20224:15 pmRNSHolding(s) in Company
30th Jun 20229:30 amRNSHolding(s) in Company
27th Jun 20223:00 pmRNSDirectorate Change
22nd Jun 20227:00 amRNSDistribution policy
6th Jun 20227:00 amRNSHolding(s) in Company
26th May 20221:15 pmRNSDirectorate Change
13th May 202212:15 pmRNSChange of Registered Office
27th Apr 20227:00 amRNSTrading Update
1st Apr 20222:00 pmRNSCompletion of Share Buyback Programme
25th Mar 20225:21 pmRNSTransaction in Own Shares
23rd Mar 20223:30 pmRNSTransaction in Own Shares
22nd Mar 20225:32 pmRNSTransaction in Own Shares
22nd Mar 20227:00 amRNSUpdate re Stefan Barden
11th Mar 20226:00 pmRNSTransaction in Own Shares
11th Mar 20223:30 pmRNSHolding(s) in Company
4th Mar 20226:25 pmRNSTransaction in Own Shares
4th Mar 202210:15 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20224:15 pmRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTrading Update
21st Feb 20223:15 pmRNSTransaction in Own Shares
18th Feb 20225:31 pmRNSTransaction in Own Shares
16th Feb 20225:30 pmRNSTransaction in Own Shares
15th Feb 202210:15 amRNSTransaction in Own Shares
14th Feb 20225:02 pmRNSTransaction in Own Shares
11th Feb 20225:15 pmRNSTransaction in Own Shares
9th Feb 20223:45 pmRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTrading Update
4th Feb 202211:45 amRNSHolding(s) in Company
24th Jan 20225:50 pmRNSTransaction in Own Shares
21st Jan 20225:15 pmRNSTransaction in Own Shares
20th Jan 20225:15 pmRNSTransaction in Own Shares
12th Jan 202212:30 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.